Navigation Links
Tufts to develop morphing 'chemical robots'
Date:6/30/2008

MEDFORD/SOMERVILLE, Mass. Scientists at Tufts University have received a $3.3 million contract from the U.S. Defense Advanced Research Projects Agency (DARPA) to develop chemical robots that will be so soft and squishy that they will be able to squeeze into spaces as tiny as 1 centimeter, then morph back into something 10 times larger, and ultimately biodegrade.

The advantages of using unmanned devices to conduct dangerous or difficult operations are clear, and the U.S. has invested in such devices for years. But today's rigid robots, constructed mostly of hard materials, are unable to navigate complex environments with openings of arbitrary size and shape. They are stymied by, say, a building whose only access points may be a crack under a door or a conduit for an electrical cable.

The Tufts team will design the "chembots" to be capable of performing feats no current machine can accomplish, according to Professor of Biology Barry Trimmer, the Henry Bromfield Pearson Professor of Natural Sciences and co-principal investigator on the project. Among these tasks will be the ability to enter confined or complex spaces; follow cables, ropes or wires; and climb trees or other branched structures.

According to Dr. Mitchell Zakin, Ph.D., DARPA program manager for the ChemBots program, "DARPA's ChemBots program represents the convergence of soft materials chemistry and robotics. It is an entirely new way of looking at robots and could someday yield great technological advantage for our armed forces."

Chembots could extend the capabilities of today's unmanned ground vehicles by accessing urban environments, tunnels, caves and debris fields. Once in place, the energy-efficient chembots could survey the area using little power and then morph to accomplish their task. For example, they might gain entry to an improvised explosive device to gather information or potentially disable the device. Other applications include landmin
'/>"/>

Contact: Kim Thurler
kim.thurler@tufts.edu
617-627-3175
Tufts University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Tufts University biologists link Huntingtons disease to health benefits in young
2. Hebrew University develops novel approach for treating mitochondrial disorders
3. New VeriEye SDK from Neurotechnology Enables Development of Reliable, Cost-effective Biometric Iris Recognition Systems
4. USGS to help Chile develop volcano early warning system
5. NJIT biomedical engineer receives NSF Career Development Award
6. Biotechnology key to developing sustainable industries says international panel
7. LIAI researchers discover new cellular mechanism that will significantly advance vaccine development
8. Engineer develops detergent to promote peripheral nerve healing
9. Taking a cue from breath fresheners, researcher develops new method for taste testing
10. UCLA researchers develop new PET scanning probe that will allowing monitoring of the immune system
11. Mouse model developed at UT Southwestern mimics hyperglycemia, aids in diabetes research
Post Your Comments:
*Name:
*Comment:
*Email:
Other Biology Technology:Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord 2Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord 3Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord 4Allen Institute for Brain Science Launches Three New Landmark Atlas Projects Focusing on the Human Brain, Developing Brain and Spinal Cord 5WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 2WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 3WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 4WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 5WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 6WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 7WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 8WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 9WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 10WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 11WuXi PharmaTech Announces Fourth Quarter and Full Year 2007 Results 12Barr Receives Approval for Generic Taxol(R) Injection USP, 6mg/mL 2Barr Receives Approval for Generic Taxol(R) Injection USP, 6mg/mL 3